Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCKBR | P32239 | 15/20 | 0.56 |
| ▸ | CCKAR | P32238 | 3/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14478158 | 0.98 | CCKBR (0.54) | CCKBRCCKAR | |
| SCHEMBL14478159 | 0.95 | CCKBR (0.57) | CCKBRCCKAR | |
| SCHEMBL14478115 | 0.95 | CCKBR (0.57) | CCKBRCCKAR | |
| SCHEMBL14478118 | 0.94 | CCKBR (0.57) | CCKBRCCKAR | |
| SCHEMBL14478155 | 0.92 | CCKBR (0.56) | CCKBRCCKAR | |
| SCHEMBL20892743 | 0.92 | CCKBR (0.55) | CCKBRCCKAR | |
| SCHEMBL20892784 | 0.92 | CCKBR (0.55) | CCKBRCCKAR | |
| SCHEMBL14478107 | 0.91 | CCKBR (0.55) | CCKBRCCKAR | |
| SCHEMBL14478125 | 0.91 | CCKBR (0.55) | CCKBRCCKAR | |
| SCHEMBL14478117 | 0.91 | CCKBR (0.57) | CCKBRCCKAR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190106460-A1 | BINDING INHIBITORS OF THE BETA. TRANSDUCIN REPEAT-CONTAINING PROTEIN | BRADLEY MARK (GB) | 2019-04-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190106460-A1 | BINDING INHIBITORS OF THE BETA. TRANSDUCIN REPEAT-CONTAINING PROTEIN | TARDBP, DDB1, EPS15 | CCKBR 4467/4885CCKAR 4751/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.